UL Solutions (ULS) Q2 2026 earnings review
Strong Organic Execution Masked by Divestiture Noise
UL Solutions delivered a solid Q2 2026, but investors must look past the headline numbers to see the true operational story. Reported Net Income skyrocketed 162% to $254M, entirely driven by a $191M pre-tax gain from the April divestiture of its EHS software business. Stripping out this noise, Adjusted EPS grew a healthy 13.5% to $0.59. The core business is performing exceptionally well: organic revenue growth accelerated to 6.6% (up from 5.7% in Q1), and Adjusted EBITDA margins expanded 140 basis points to 26.8%. The Consumer segment, which lagged in Q1, rebounded sharply. However, capital intensity is quietly increasing, with CapEx guidance raised to 8.5% of revenue.
🐂 Bull Case
Adjusted EBITDA margins expanded 140 bps year-over-year to 26.8%. The ongoing restructuring plan and operating leverage are successfully offsetting wage and FX inflation.
After a weak Q1 (+3.0% organic), the Consumer segment accelerated to 6.2% organic growth, while simultaneously driving a massive 310 bps improvement in Adjusted EBITDA margins.
🐻 Bear Case
Despite divesting the 'slower growing' EHS business, the remaining Risk & Compliance Software segment posted only 4.8% organic growth, lagging the corporate average of 6.6%.
Management raised FY26 CapEx guidance to ~8.5% of revenue (up from 7-8% guided in Q1), signaling that keeping pace with advanced testing needs (batteries, data centers) will weigh on free cash flow conversion.
⚖️ Verdict: 🟢
Bullish. The underlying operating momentum is excellent. The company successfully executed a major portfolio refinement, accelerated organic growth, and expanded margins in a choppy macro environment.
Key Themes
Portfolio Transformation Executed
Q2 results were heavily distorted by the April 1st closure of the EHS software divestiture. This generated a massive $191M gain on sale but created a $14M revenue void in the quarter. This cash infusion bolsters the balance sheet ahead of the pending €575 million acquisition of Eurofins E&E (expected to close in Q4), transitioning capital from lower-synergy software into core testing, inspection, and certification (TIC) markets in EMEA and APAC.
Consumer Segment Reversing Weakness
The Consumer segment flipped from a Q1 laggard to a primary growth engine in Q2. Organic revenue growth accelerated from 3.0% in Q1 to 6.2% in Q2. More impressively, operating leverage was massive: Adjusted EBITDA margin expanded 310 basis points year-over-year to 21.3%. This validates management's Q1 claim that early weakness was merely a difficult comparative period rather than structural demand destruction.
Industrial Megatrends Provide Stable Base
The Industrial segment remains the bedrock of ULS, delivering 7.2% organic growth and flat, highly profitable Adjusted EBITDA margins of 32.3%. Sustained demand for energy transition testing, automation, and critical infrastructure for data centers continues to provide a durable pipeline of testing and certification volumes.
Risk & Compliance Software Growth Disappoints
Management previously noted that the divested EHS software business was 'slightly slower growing' than the remaining software portfolio, implying growth should accelerate post-sale. Yet, the remaining Risk & Compliance Software segment generated just 4.8% organic growth in Q2—the lowest of all three segments and well below the 6.6% corporate average. This contradiction suggests the core software offerings may lack the intended momentum.
Quiet Increase in Capital Intensity
Buried in the guidance is a notable acceleration in capital requirements. FY26 CapEx is now guided to ~8.5% of revenue, a step up from the 7.0-8.0% range provided in Q1, and significantly higher than the 6.4% realized in FY25. While investing in advanced labs (battery, EV, HVAC) is necessary to capture megatrend growth, it represents a structural headwind to free cash flow margins.
Restructuring Benefits Reaching the Bottom Line
The margin expansion story is playing out exactly as guided. Consolidated Adjusted EBITDA margins expanded 140 basis points to 26.8%. This proves the late-2025 restructuring plan—which shed ~1% of low-margin revenue to improve operating model efficiency—is actively translating into higher profitability despite a complex global backdrop.
Other KPIs
Accelerating. Up 15.8% from $208M in the prior year period. Strong net income and working capital management generated $379M in operating cash flow, easily funding the $138M in capital expenditures. This liquidity allowed for $191M in net debt repayments during the half.
A massive 161.9% YoY increase, but highly distorted. The jump from $97M in Q2 2025 is almost entirely attributable to the $191M pre-tax gain on the sale of the EHS software business. Adjusted Net Income, which strips out this one-time event, grew a more realistic 17.3% to $129M.
Guidance
Stable. The company maintained its constant currency organic growth outlook. Given H1 2026 delivered ~6.1% organic growth, this guidance suggests steady performance into H2, keeping in mind the ~1% drag from restructuring exits.
Stable compared to the Q1 updated guide, but represents an acceleration versus the 25.9% margin achieved in FY25. With H1 coming in at 26.4%, the company will need to average slightly over 27.5% in H2 to hit this target—consistent with historical seasonality.
Accelerating. Raised from the prior expectation of 7% to 8%. Assuming 'mid-single-digit' revenue growth equates to roughly $3.2B in total sales, this implies CapEx of ~$272M, a substantial jump from the $197M spent in FY25.
Key Questions
Software Segment Organic Growth
With the divestiture of the slower-growing EHS software business complete, why did the remaining Risk & Compliance Software segment only generate 4.8% organic growth? When should we expect this segment to outpace the corporate average?
CapEx Outlook Revision
CapEx guidance was revised upward to roughly 8.5% of revenue. Which specific testing capacities or regions required this incremental step-up in investment during the quarter?
Consumer Segment Sustainability
The Consumer segment showed a dramatic margin recovery and organic growth acceleration in Q2. How much of this was catch-up from a sluggish Q1 versus a structural improvement in baseline demand?